Pre-transplant depression as risk factor for survival of patients undergoing allogeneic haematopoietic stem cell transplantation

被引:46
作者
Grulke, Norbert [1 ]
Larbig, Wolfgang [2 ]
Kaechele, Horst [1 ]
Bailer, Harald [1 ]
机构
[1] Univ Ulm, Univ Klin Psychosomat Med & Psychotherapie, D-89075 Ulm, Germany
[2] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany
关键词
cancer; oncology; haematopoietic stem cell transplantation; depression; survival;
D O I
10.1002/pon.1261
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Depression is discussed as a possible risk factor for survival in cancer patients. We explored this relationship for patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT). Patients and methods: The depression subscale of the Hospital Anxiety and Depression Scale (HADS) served as a measure for depression. One hundred and thirty-eight patients (mean age 41 years; different diagnoses) participating in a psycho-oncology study filled in the HADS after admission for allogeneic HSCT. They were followed-up for at least two years; 72 patients died during follow-up. Results: Depression scores were not correlated with medical and psychosocial objective factors with the exception of having under-aged children. Controlling for medical factors that showed up as predictors for survival in our sample (patient's age at HSCT, having had a transplant before, risk for treatment failure) the HADS depression score (range 0-21) emerged as an independent predictor (Cox regression): hazard ratio = 1.087; 95% Cl = 1.018-1.161. Conclusion: Depression is probably not a simple indicator of a worse health status. Further research is needed to decide if depression must be considered as an independent risk factor for survival when diagnosed in the pre-transplant period. Copyright (C) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:480 / 487
页数:8
相关论文
共 28 条
  • [1] Psychological factors and survival after bone marrow transplantation in patients with leukemia
    Akaho, R
    Sasaki, T
    Mori, SI
    Akiyama, H
    Yoshino, M
    Hagiya, K
    Nakagome, K
    Sakamaki, H
    [J]. PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2003, 57 (01) : 91 - 96
  • [2] Depression and survival after hematopoietic stem cell transplantation: Where do we go from here?
    Andrykowski, MA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 5878 - 5880
  • [3] BAILER H, VERHALTENST IN PRESS
  • [4] BJELLAND I, 2002, J PSYCHOSOM RES, V0052
  • [5] Bottomley A, 1998, Eur J Cancer Care (Engl), V7, P181
  • [6] Prognostic index for adult patients with acute myeloid leukemia in first relapse
    Breems, DA
    Van Putten, WLJ
    Huijgens, PC
    Ossenkoppele, GJ
    Verhoef, GEG
    Verdonck, LF
    Vellenga, E
    De Greef, G
    Jacky, E
    Van der Lelie, J
    Boogaerts, MA
    Löwenberg, B
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (09) : 1969 - 1978
  • [7] Cohen J., 1988, POWERSTATISTICALSCIE, DOI 10.4324/9780203771587
  • [8] FALLER H, 2004, Z MED PSYCHOL, V13, P99
  • [9] Allogeneic BMT and patient eligibility based on psychosocial criteria: a survey of BMT professionals
    Foster, LW
    McLellan, LJ
    Rybicki, LA
    Dabney, J
    Welsh, E
    Bolwell, BJ
    [J]. BONE MARROW TRANSPLANTATION, 2006, 37 (02) : 223 - 228
  • [10] Is perceived social support a predictor of survival for patients undergoing autologous peripheral blood stem cell transplantation?
    Frick, E
    Motzke, C
    Fischer, N
    Busch, R
    Bumeder, I
    [J]. PSYCHO-ONCOLOGY, 2005, 14 (09) : 759 - 770